Feedback / Questions
AU-007 - Aulos Biosci
https://www.businesswire.com/news/home/20230525005875/en/Interim-Results-From-Phase-12-Clinical-Trial-in-Solid-Tumor-Cancers-Demonstrate-Aulos-Bioscience%E2%80%99s-AU-007-is-Well-Tolerated-and-Uniquely-Reduces-Regulatory-T-Cells
May 25, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next